AbbVievsAvantor

ABBV and AVTR stock compared: price, dividend, valuation and results, from SEC filings.

AbbVie (ABBV) has a market value of $522B and Avantor (AVTR) $10.6B. Over the last year, with dividends, ABBV moved +30.3% and AVTR +34.5%. The P/E is 50.7 for ABBV and 31.4 for AVTR. Dividend yield: ABBV 2.35%, AVTR none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    AVTR$10.6B

    ABBV is 49 times AVTR

  • Revenue, 12 months

    ABBV$66.0B

    AVTR$6.6B

    ABBV is 9.9 times AVTR

  • Net income, 12 months

    ABBV$10.3B

    AVTR$337M

    ABBV is 31 times AVTR

  • Operating margin

    ABBV32.2%

    AVTR7.3%

    24.9 points apart

  • ROIC

    ABBV25.7%

    AVTR4.1%

    21.6 points apart

  • P/E

    ABBV50.7

    AVTR31.4

    ABBV is 1.6 times AVTR

  • Dividend yield

    ABBV2.4%

    AVTR0.0%

    2.4 points apart

  • 5-year return

    ABBV+201.5%

    AVTR-59.1%

    260.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.6%

AVTR-59.1%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsAVTRWith dividends
1 year since November 12, 2025+30.3%Price +26.5%+34.5%Price +34.5%
3 years since November 13, 2023+135.3%+33.0% a yearPrice +112.8%-16.5%-5.8% a yearPrice -16.5%
5 years since November 12, 2021+201.5%+24.7% a yearPrice +152.2%-59.1%-16.4% a yearPrice -59.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieAVTRAvantor

Valuation

ABBVAVTR
Valuation
Price$295.03$15.54
Market value$522B$10.6B
Enterprise value (EV)$592B$13.8B
P/E50.731.4
P/E, 5-year median57.034.7
P/B–1.8
EV/EBIT27.928.4
Free cash flow yield3.6%4.1%

Results and growth

ABBVAVTR
Results and growth
Revenue, 12 months$66.0B$6.6B
Net income, 12 months$10.3B$337M
Free cash flow, 12 months$18.9B$439M
Earnings per share, 12 months$5.81$0.50
Revenue growth, year on year8.6%-3.4%
Revenue growth a year, past+5.9%over 5 years+0.5%over 5 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVAVTR
Margins and returns on capital
Gross margin73.7%31.6%
Operating margin32.2%7.3%
Net margin15.7%5.1%
ROIC25.7%4.1%
ROE–6.0%

Balance sheet

ABBVAVTR
Balance sheet
Cash$10.8B$464M
Total debt$80.9B$3.7B
Net debt / EBITDA3.23.6
Interest cover7.1×3.0×

Dividends and buybacks

ABBVAVTR
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%0.7%
Shareholder yield2.5%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or AVTR

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Avantor?

By market value, AbbVie ($522B) is about 49.2 times Avantor ($10.6B), at today's prices.

How did ABBV and AVTR stock do over the last 5 years?

Since November 12, 2021, ABBV's price moved +152.2% and AVTR's -59.1%. With dividends: ABBV +201.5% (+24.7% a year), AVTR -59.1% (-16.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or AVTR?

The dividend yield at today's price is 2.35% for AbbVie and none for Avantor. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and AVTR?

At today's price, the P/E is 50.7 for ABBV and 31.4 for AVTR. The median of the last five years was 57.0 and 34.7, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Avantor?

Over the last twelve months, the net margin was 15.7% for AbbVie and 5.1% for Avantor, and the operating margin 32.2% and 7.3%. Revenue was $66.0B and $6.6B.

Which is the better investment, AbbVie or Avantor?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.